ArticleHuman pathology2019

Targeted sequencing of plasmacytoid urothelial carcinoma reveals frequent TERT promoter mutations.

Doreen N Palsgrove et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.